期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Regulatory evaluation of efficacy and safety of new drugs in China
1
作者 ZHANGXiang-lin ValerioReggi VittorioBertele' 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第2期320-320,共1页
Accessibility, availability, and rational use of medicines are widely recognized priorities for guaranteeing equity in health care. Commercial pressure can twist health policy if pharmaceutical companies are allowed t... Accessibility, availability, and rational use of medicines are widely recognized priorities for guaranteeing equity in health care. Commercial pressure can twist health policy if pharmaceutical companies are allowed to promote and impose their products beyond clear public-health interest. National regulatory 展开更多
关键词 regulatory evaluation of efficacy and safety of new drugs in China
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部